Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation

Magnetic Resonance in Medicine

Volumn 53, Issue 6, 2005, Pages 1307-1316

  Quarles, C C ^a   Ward, B D ^a   Schmainda, Kathleen M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Angiogenesis; Contrast agent leakage; DSC MRI; Glioma; Tumor hemodynamics

Indexed keywords

MAGNETIC SUSCEPTIBILITY; SIGNAL SYSTEMS; TUMORS;

ANGIOGENESIS; CONTRAST AGENT; DSC MRI; DYNAMIC SUSCEPTIBILITY CONTRAST MRIS; GLIOMA; GRADIENT ECHO SEQUENCES; HEMODYNAMIC PARAMETERS; MODEL BASED TECHNIQUES;

HEMODYNAMICS;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CALCULATION; COMPUTER SIMULATION; CONTRAST ENHANCEMENT; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; GLIOMA; HEMODYNAMICS; MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; RELIABILITY; TECHNIQUE; TUMOR DIAGNOSIS;

EID: 19544371021     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20497     Document Type: Article

References (37)

1. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989;49:6449-6465.
2. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003;9: 685-693.
3. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 1988;133:95-109.
4. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-1039.
5. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988;48:2641-2658.
6. Gillies RJ, Schornack PA, Secomb TW, Raghunand N. Causes and effects of heterogeneous perfusion in tumors. Neoplasia 1999;1:197-207.
7. Tofts P, Kermode A. Measurement of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1991;17:357-367.
8. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.
9. Gossmann A, Helbich TH, Kuriyama N, Ostrowitzki S, Roberts TP, Shames DM, van Bruggen N, Wendland MF, Israel MA, Brasch RC. Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme. J Magn Reson Imaging 2002;15:233-240.
10. Aronen HJ, Cohen MS, Belliveau JW, Fordham JA, Rosen BR. Ultrafast imaging of brain tumors. Top Magn Reson Imaging 1993;5:14-24.
11. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41-51.
12. Donahue KM, Krouwer HG, Rand SD, Pathak AP, Marszalkowski CS, Censky SC, Frost RW. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000;43:845-853.
13. Ostergaard L, Hochberg FH, Rabinov JD, Sorensen AG, Lev M, Kim L, Weisskoff RM, Gonzalez RG, Gyldensted C, Rosen BR. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg 1999;90: 300-305.
14. Schmainda KM, Rand SD, Joseph A, Ward BD, Lund R, Pathak AP, Ulmer J, Baddrudoja M, Krouwer HG. Characterization of a first-pass gradient-echo:spin- echo method to predict brain tumor grade and angiogenesis. Am J Neuroradiol 2004;25:1524-1532.
15. Packard SD. CBF and CBV are mismatched in rat model of human glioma. In: Proceedings of the 8th Annual Meeting of ISMRM, Denver, 2000.
16. Packard SD, Ichikawa T, Mandeville JB, Chiocca EA, Rosen BR, Marota JJA. Tumor perfusion effeciency and mean vessel size measured in experimental human gliomas. In: Proceedings of the 9th Annual Meeting of ISMRM, Glasgow, Scotland, 2001. p 477.
17. Ostergaard L, Chesler DA, Weisskoff RM, Sorensen AG, Rosen BR. Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data. J Cereb Blood Flow Metab 1999;19:690-699.
18. Ostergaard L, Sorensen AG, Chesler DA, Weisskoff RM, Koroshetz WJ, Wu O, Gyldensted C, Rosen BR. Combined diffusion-weighted and perfusion-weighted flow heterogeneity magnetic resonance imaging in acute stroke. Stroke 2000;31:1097-1103.
19. Weisskoff RM, Boxerman JL, Sorensen AG, Kulke S, T. C., Rosen BR. Simultaneous blood volume and permeability mapping using a single Gd-based contrast injection. In: Proceedings of the 2nd Annual Meeting of ISMRM, San Francisco, 1994. p 279.
20. Bruening R, Kwong KK, Vevea MJ, Hochberg FH, Cher L, Harsh GRt, Niemi PT, Weisskoff RM, Rosen BR. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. Am J Neuroradiol 1996;17:831-840.
21. Heiland S, Benner T, Debus J, Rempp K, Reith W, Sartor K. Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain-barrier. Magn Reson Imaging 1999;17:21-27.
22. Vonken EJ, van Osch MJ, Bakker CJ, Viergever MA. Measurement of cerebral perfusion with dual-echo multi-slice quantitative dynamic susceptibility contrast MRI. J Magn Reson Imaging 1999;10:109-117.
23. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725.
24. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med 1996;36:726-736.
25. Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 2000;44:466-473.
26. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 1994;31:601-610.
27. Liu HL, Pu Y, Liu Y, Nickerson L, Andrews T, Fox PT, Gao JH. Cerebral blood flow measurement by dynamic contrast MRI using singular value decomposition with an adaptive threshold. Magn Reson Med 1999;42: 167-172.
28. Perkio J. Aronen HJ, Kangasmaki A, Liu Y, Karonen J, Savolainen S, Ostergaard L. Evaluation of four postprocessing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging. Magn Reson Med 2002;47:973-981.
29. Knopp E, Cha S, Johnson G, Mazumdar A, Golfinos J, Zagzag D, Miller D, Kelly P, Kricheff I. Glial Neoplasms: Dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791-798.
30. Delile J, Slanetz P, Yeh E, Kopans D, Garrido L. Breast cancer: regional blood flow and volume with magnetic susceptibility-based MR imaging. Radiology 2002;223:558-565.
31. Fuss M, Wenz F, Scholdei R, Essig M, Debus J, Knopp MV, Wannenmacher M. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence. Int J Radiat Oncol Biol Phys 2000;48:53-58.
32. Fuss M, Wenz F, Essig M, Muenter M, Debus J, Herman TS, Wannenmacher M. Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. Int J Radiat Oncol Biol Phys 2001;51:478-482.
33. Hobbs SK, Shi G, Homer R, Harsh G, Atlas SW, Bednarski MD. Magnetic resonance image-guided proteomics of human glioblastoma multiforme. J Magn Reson Imaging 2003;18:530-536.
34. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003;21:1624-1636.
35. Boxerman JL, Rosen BR, Weisskoff RM. Signal-to-noise analysis of cerebral blood volume maps from dynamic NMR imaging studies. J Magn Reson Imaging 1997;7:528-537.
36. Johnson G, Wetzel SG, Cha S, Babb J, Tofts PS. Measuring blood volume and vascular transfer constant from dynamic, T2*-weighted contrast-enhanced MRI. Magn Reson Med 2004;51:961-968.
37. Uematsu H, Maeda M, Sadato N, Matsuda T, Ishimori Y, Koshimoto Y, Kimura H, Yamada H, Kawamura Y, Yonekura Y, Itoh H. Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study. Am J Neuroradioly 2001;22:1915-1919.